2024-05-23T13:06:33-05:00 2023-12-31 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 800N BETHESDA MD 208142930 990 2023-01-01 522187678 BIOONE BIOO 2022962296 21 DUPONT CIRCLE NW 800 WASHINGTON DC 200361118 LAUREN P KANE PRESIDENT/CEO 2022962296 2024-05-23 1 LAUREN KANE 999009999 0 RICHARD J LOCASTRO CPA P00288314 3019519090 3 AAL1 IAL1 2023 2023-04-26 12:10:37Z LAUREN P KANE 21 DUPONT CIRCLE NW 800 WASHINGTON DC 200361118 12928293 0 X WWW.BIOONE.ORG X 1999 DC SEE PART III, LINE 1. 13 12 8 25 0 0 0 0 11321284 12570821 169650 357223 5686 249 11496620 12928293 0 0 0 0 1144007 1384366 0 0 0 8655368 10077012 9799375 11461378 1697245 1466915 12202506 13198044 7571562 7714894 4630944 5483150 X BIOONE SEES SUSTAINABLE SCHOLARLY COMMUNICATIONS AS AN INHERENTLY COLLABORATIVE ENTERPRISE CONNECTING AUTHORS, NONPROFIT PUBLISHERS, SOCIETIES, ACADEMIC INSTITUTIONS, RESEARCH LIBRARIES, AND RESEARCH FUNDERS IN THE COMMON GOAL OF MAXIMIZING ACCESS TO CRITICAL RESEARCH. CONTINUATION OF ORGANIZATION'S MISSION FROM PAGE 2. BIOONE EXPLORES ECONOMIC MODELS AND STRATEGIC PARTNERSHIPS THAT BALANCE THE NEEDS OF ALL STAKEHOLDERS, AND CURRENTLY DEMONSTRATES THIS BALANCE BY OFFERING FINANCIALLY SUSTAINABLE INFORMATION SERVICES IN THE BIOLOGICAL SCIENCES. BIOONE SUPPORTS BEST PRACTICES THAT INCREASE OPERATIONAL EFFECTIVENESS AND TECHNOLOGICAL STANDARDS THAT INTEGRATE ITS CONTENT WITH A GLOBAL NETWORK OF SCHOLARY EXCHANGE. 1 0 9240220 12274546 BIOONE COMPLETE: BIOONE COMPLETE IS THE ORGANIZATION'S FLAGSHIP PRODUCT, A FULL-TEXT AGGREGATED JOURNAL DATABASE LICENSED AS A SINGLE PACKAGE TO INDIVIDUAL EDUCATIONAL AND RESEARCH INSTITUTIONS, OFTEN THROUGH LIBRARY CONSORTIA AND SALES INTERMEDIARIES. IN 2023, BIOONE COMPLETE CONTAINED 218 TITLES FROM 156 NOT-FOR-PROFIT PUBLISHERS. THE MAJORITY OF SALES REVENUE FOR BIOONE COMPLETE IS RETURNED TO CURRENT PUBLISHERS THROUGH BIOONE'S REVENUE SHARING MODEL. 121006 152950 BIOONE EBOOK COLLECTIONS: BIOONE LAUNCHED ITS FIRST PUBLISHER EBOOK COLLECTION IN 2023, WHICH INCLUDED 163 TITLES FROM THE ENTOMOLOGICAL SOCIETY OF AMERICA, DIGITIZED AND AVAILBLE ONLINE FOR THE FIRST TIME. EBOOK COLLECTIONS ARE SOLD AS A ONE-TIME PACKAGE PURCHASE TO INDIVIDUAL EDUCATIONAL AND RESEARCH INSTITUTIONS, SOMETIMES THROUGH LIBRARY CONSORTIA AND SALES INTERMEDIARIES. NET REVENUE IS SPLIT WITH THE PARTICIPATING PUBLISHER AND IS DISTINCT FROM JOURNAL SALES AND REVENUE SHARING. 56666 105710 BIOONE COMPLETE ARCHIVE: THE BIOONE COMPLETE ARCHIVE IS A DERIVATIVE PRODUCT OF BIOONE COMPLETE, COMPRISED OF PARTICIPATING TITLES' FULL-TEXT JOURNAL CONTENT WHICH IS MORE THAN FIVE (5) YEARS OLD. THE BIOONE COMPLETE ARCHIVE IS SOLD AS A ONE-TIME PACKAGE PURCHASE TO INDIVIDUAL EDUCATIONAL AND RESEARCH INSTITUTIONS, SOMETIMES THROUGH LIBRARY CONSORTIA AND SALES INTERMEDIARIES. IN 2023, THE BIOONE COMPLETE ARCHIVE CONTAINED 177 TITLES FROM 128 NOT-FOR-PROFIT PUBLISHERS. THE MAJORITY OF SALES REVENUE FOR THE BIOONE COMPLETE ARCHIVE IS RETURNED TO PARTICIPATING PUBLISHERS THROUGH BIOONE'S REVENUE SHARING MODEL. 6080 EDUCATION PROGRAM: THE BIOONE AMBASSADOR AWARD RECOGNIZES EARLY-CAREER AUTHORS IN BIOONE COMPLETE TITLES AND INSPIRES CREATIVE APPROACHES TO COMMUNICATING SPECIALIZED RESEARCH TO THE GENERAL PUBLIC. FOR THE 2023 AWARD, CURRENT BIOONE PUBLISHING PARTNERS NOMINATED OUTSTANDING SCHOLARS WHO PUBLISHED AN ARTICLE IN A BIOONE COMPLETE JOURNAL DURING 2022. THE WINNING ENTRIES BY THESE AUTHORS ENGAGE READERS BY HIGHLIGHTING THE IMPORTANCE OF THEIR RESEARCH AT A LOCAL AND GLOBAL LEVEL AND RECEIVE A CASH AWARD. 13090 37615 BIOONE OPEN ACCESS: BIOONE HOSTS OPEN ACCESS TITLES AND FULLY INTEGRATES THIS CONTENT IN BIOONE COMPLETE. LIKE THEIR SUBSCRIBED COUNTERPARTS, THE CURRENT CONTENTS OF BIOONE OPEN ACCESS TITLES ARE PRESENTED IN FULL-TEXT. BIOONE OPEN ACCESS TITLES ARE FREELY AVAILABLE TO ALL USERS IRRESPECTIVE OF SUBSCRIPTION. IN 2023, THE OPEN ACCESS COLLECTION INCLUDED 19 CURRENT FULLY OPEN ACCESS TITLES. THIS PROGRAM AIMS TO BE SELF-SUSTAINING, THUS BIOONE CHARGES PARTICIPATING TITLES A FLAT, PER-PUBLISHED PAGE RATE. 19170 37615 9437062 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 8 0 1 8 1 0 0 0 0 0 0 0 0 0 0 0 0 X 13 12 0 0 1 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 X X LAUREN P KANE 2025409972 21 DUPONT CIRCLE NW SUITE 800 WASHINGTON DC 20036 ALAN SAVITZKY BOARD DIRECTOR & CHAIR 2.00 X X 0 0 0 CATHERINE MURRAY-RUST BOARD DIR, VICE CHAIR & TREASURER 2.00 X X 0 0 0 JONI BLAKE BOARD DIRECTOR & SECRETARY 2.00 X X 0 0 0 RAYM CROW SCHEDULE L BOARD DIRECTOR 1.00 X 0 0 0 TARAN GRANT BOARD DIRECTOR 1.00 X 0 0 0 ROBBIE HART BOARD DIRECTOR 1.00 X 0 0 0 CHRIS MAKOWSKI BOARD DIRECTOR 1.00 X 0 0 0 ERIC S NAGY BOARD DIRECTOR 1.00 X 0 0 0 A TOWNSEND PETERSON BOARD DIRECTOR 1.00 X 0 0 0 MIRA WALLER BOARD DIRECTOR 1.00 X 0 0 0 JAMES F WILLIAMS II BOARD DIRECTOR 1.00 X 0 0 0 ANS TER WOERDS BOARD DIRECTOR 1.00 X 0 0 0 KAMRAN NAIM BOARD DIRECTOR 1.00 X 0 0 0 LAUREN KANE PRESIDENT/CEO 40.00 X 297000 0 54042 ELIZABETH HUTCHINS DIR. OF OPERATIONS & TECHN 40.00 X 152490 0 35386 CHRISTINE E ORR DIR. OF SALES & COMM. ENGAGEMENT 40.00 X 162500 0 39752 CHELSEA THARP ASSOCIATE DIRECTOR OF SALES 40.00 X 123873 0 24021 735863 0 153201 4 0 1 0 SPIE 1000 20TH STREET BELLINGHAM WA 99225 TECHNOLOGY SERVICES 450797 INNODATA ISOGEN INC 55 CHALLENGER ROAD S-202 RIDGEFIELD PARK NJ 07600 DATA CONVERSION SERVICE 155592 CHAIN BRIDGE GROUP PO BOX 429 FLINT HILL VA 22627 CONSULTING 127175 ACCUCOMS INC 1816 WEST POINT PIKE 125 LANSDALE PA 19446 SALES 122160 ASSOCIATION OF RESEARCH LIBRARIES 21 DUPONT CIR NW 800 WASHINGTON DC 20036 ADMIN. SERVICES 120536 6 PUBLICATIONS 900099 12487287 12487287 ANCILLARY REVENUE 900099 45635 45635 OPEN ACCESS INCOME 900099 37615 37615 REFERRAL FEES 900099 284 284 12570821 357223 357223 OTHER REVENUE 900099 249 249 249 12928293 12570821 0 357472 351042 351042 772130 772130 106275 106275 79282 79282 75637 75637 137348 137348 13962 13962 844 844 59497 49749 9748 34594 2697 31897 660380 628995 31385 3918822 3918822 17773 17773 82043 277 81766 7266 7266 98080 98080 39550 39550 DISCOUNTS/COMMISSIONS 4682830 4682830 STRATEGIC EXPENDITURES 153500 150000 3500 ADMINISTRATIVE EXP. 115795 115795 STAFF DEVELOPMENT 24217 24217 30511 3692 26819 11461378 9437062 2024316 0 7894892 8004019 274769 355624 75903 62089 3858862 4776312 98080 0 12202506 13198044 297165 495706 2307811 2312708 4966586 4906480 7571562 7714894 X 4630944 5483150 4630944 5483150 12202506 13198044 X 1466915 372950 -987659 X 0 1 X 1 0 X 145400 145400 11857183 12159025 12630960 11321284 12570821 60539273 11857183 12159025 12776360 11321284 12570821 60684673 0 0 0 60684673 149379 95863 167797 169650 357223 939912 149379 95863 167797 169650 357223 939912 183116 273 5686 249 189324 12189678 12255161 12944157 11496620 12928293 61813909 0.98170 0.98210 0.01520 0.01160 X 4630944 852206 5483150 4729528 98584 4630944 3647662 1081866 4729528 3042607 605055 3647662 2033345 1009262 3042607 1.00000 0.00000 0.00000 0 0 0 ROYALTY EXPENSE PAYABLE 3918821 SURPLUS SHARE PAYABLE 987659 4906480 13290481 372950 3200 376150 12914331 13962 13962 12928293 11443413 3200 3200 11440213 13962 7203 21165 11461378 PART V, LINE 4: BOARD-DESIGNATED OPERATIONAL FUND CONTAINS A 6-MONTH RESERVE FOR OPERATIONAL EXPENSES. BOARD-DESIGNATED CAPITAL FUND WILL ALLOW THE ORGANIZATION TO MAKE IMPROVEMENTS AND ADD PROGRAMS TO SERVE THE FUTURE NEEDS OF BIOONE'S COMMUNITY. PART XII, LINE 4B - OTHER ADJUSTMENTS: FORM 990, PART IX, LINE 24 FOREIGN CURRENCY LOSS - REPORTED AS AN OTHER ITEM ON THE FINANCIAL STATEMENTS AND REPORTED AS AN EXPENSE ON FORM 990, PART IX, LINE 24 7,203. X X X 0 0 0 0 0 0 0 1 0 LAUREN KANE PRESIDENT/CEO 297000 0 0 0 0 0 44550 0 9492 0 351042 0 0 0 CHRISTINE E ORR DIR. OF SALES & COMM. ENGAGEMENT 152500 0 10000 0 0 0 22875 0 16877 0 202252 0 0 0 ELIZABETH HUTCHINS DIR. OF OPERATIONS & TECHN 152490 0 0 0 0 0 22875 0 12511 0 187876 0 0 0 PART I, LINE 7 CHRISTINE E. ORR RECEIVED A BONUS AMOUNT AS LISTED ON PART II, COLUMN B(III). IN ADDITION, CHELSEA THARP RECEIVED A BONUS IN THE AMOUNT OF $23,873. CHAIN BRIDGE GROUP RAYM CROW, BOARD DIRECTOR AND OWNER OF CHAIN BRIDGE GROUP 127175 BIOONE PAID FOR CHAIN BRIDGE GROUP (CBG) FOR CONSULTING SERVICES THAT CBG IS UNIQUELY QUALIFIED TO PERFORM IN RELATION TO BIOONE'S OPEN ACCESS BUSINESS MODEL INVESTIGATION. THESE SERVICES ARE SEPARATE FROM HIS BOARD MEMBER DUTIES AND WERE NEGOTIATED AT ARM'S LENGTH. 0 SCH L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: BIOONE RETAINED CHAIN BRIDGE GROUP (CBG) FOR CONSULTING SERVICES THAT CBG IS UNIQUELY QUALIFIED TO PERFORM IN RELATION TO BIOONE'S OPEN ACCESS BUSINESS MODEL INVESTIGATION. CBG'S UNIQUE QUALIFICATIONS, COMPETITIVE PROPOSAL, AND ABILITY TO WORK AT ARM'S LENGTH WERE ALL ASSESSED BY THE BIOONE BOARD OF DIRECTORS IN DISCUSSIONS WHERE DIRECTOR CROW WAS RECUSED. ALL CONSULTING SERVICES PERFORMED THROUGH CBG ARE SEPARATE AND DISTINCT FROM CROW'S BOARD MEMBER DUTIES WHERE HE IS AN APPOINTED REPRESENTATIVE OF THE ACTIVE FOUNDING ORGANIZATION SPARC, AND NOT A DIRECTOR-AT-LARGE. BIOONE'S AUDIT AND OVERSIGHT COMMITTEE WILL CONTINUE TO MONITOR THE ENGAGEMENT AND SPECIAL CARE WILL BE TAKEN TO ENSURE THERE IS NO CONFLICT OF INTEREST PRESENT. FORM 990, PART III, LINE 2 THE ORGANIZATION BEGAN A NEW PROGRAM, BIOONE EBOOK COLLECTIONS. FORM 990, PART VI, SECTION A, LINE 4 THE BYLAWS WERE UPDATED IN MAY 2023, WITH THE MOST SIGNIFICANT CHANGE BEING THE REMOVAL OF A FOUNDING ORGANIZATION FROM "ACTIVE" STATUS. FORM 990, PART VI, SECTION A, LINE 6 BIOONE HAS FIVE FOUNDING ORGANIZATIONS, THREE OF WHICH ARE ABLE TO APPOINT DIRECTORS ACCORDING TO THE ORGANIZATION'S BYLAWS. FORM 990, PART VI, SECTION A, LINE 7A ACCORDING TO THE ORGANIZATION'S BYLAWS, BIOONE'S BOARD OF DIRECTORS SHALL BE COMPOSED OF THREE MEMBERS APPOINTED BY THE THREE ACTIVE FOUNDING ORGANIZATIONS AND UP TO 12 AT LARGE MEMBERS ELECTED BY THE BOARD. THE THREE ACTIVE FOUNDING ORGANIZATIONS WITH THESE APPOINTMENT RIGHTS ARE: THE AMERICAN INSTITUTE OF BIOLOGICAL SCIENCES, THE SCHOLARLY PUBLISHING AND ACADEMIC RESOURCES COALITION, AND THE GREATER WESTERN LIBRARY ALLIANCE. NO INDIVIDUAL MEMBER OF THE GOVERNING BOARD HAS THE POWER TO APPOINT SOMEONE TO THE BOARD. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS DISTRIBUTED TO BIOONE'S AUDIT AND OVERSIGHT COMMITTEE (AOC), WHICH REVIEWED THE FORM FOR ACCURACY, AND MADE A REPORT TO THE FULL BOARD OF DIRECTORS AT ITS NEXT MEETING. IF THERE ARE ANY QUESTIONS OR PROBLEMS RAISED BY THE AOC, DETAILS ARE WORKED THROUGH WITH BIOONE MANAGEMENT. THE FINAL DOCUMENT IS SUBMITTED TO THE ENTIRE BOARD OF DIRECTORS, AND REVIEWED A FINAL TIME BY THE AOC, BEFORE FILING WITH THE IRS. THE FORM 990 IS ALSO POSTED ON THE ORGANIZATION'S WEBSITE. FORM 990, PART VI, SECTION B, LINE 12C BIOONE HAS ADOPTED A CODE OF ETHICS, CONFLICT OF INTEREST, ANTI-FRAUD AND INCLUSIVITY POLICIES THAT ARE DISTRIBUTED TO STAFF AND ALL DIRECTORS AND OFFICERS. THESE DOCUMENTS ARE REVIEWED AND REDISTRIBUTED AS PART OF AN ANNUALLY UPDATED HANDBOOK FOR THE BOARD OF DIRECTORS. MONITORING AND ENFORCEMENT OF THESE POLICIES ARE DONE AT EACH MEETING OF THE BOARD WHEN ISSUES ARE RAISED THAT COULD POTENTIALLY BE CONSIDERED CONFLICTS OF INTEREST. IF A DIRECTOR FEELS THAT THERE IS A CONFLICT, THEY LEAVE THE MEETING, THE ACTION AND REASON ARE DOCUMENTED IN THE MINUTES, AND IF NECESSARY, DETAILS OF THE DECISION ARE CAREFULLY EXPUNGED FROM THE SET OF MINUTES DISTRIBUTED TO THAT DIRECTOR FOLLOWING THE MEETING. DIRECTORS SIGN ANNUALLY A FORMAL DISCLOSURE STATEMENT. ORIGINALS ARE KEPT IN THE BIOONE HQ OFFICE AND IN A SECURE LOCATION ONLINE. FORM 990, PART VI, SECTION B, LINE 15 THE PRESIDENT/CEO'S COMPENSATION FOR 2023 WAS INFORMED BY HER EMPLOYMENT CONTRACT, SIGNED IN AUGUST 2021, WHICH PROVIDES EVALUATION CRITERIA FOR ANNUAL INCREASES, DETERMINED BY THE EXECUTIVE COMMITTEE/COMPENSATION COMMITTEE EACH FALL. IN ASSESSING THE PRESIDENT/CEO'S COMPENSATION AND ANNUAL ADJUSTMENTS, THE COMMITTEE CONSIDERS COMPARABLE DATA FROM SIMILAR SIZED NON-PROFIT ORGANIZATIONS, PUBLISHED COMPENSATION REPORTS BY PROMINENT ORGANIZATIONS, AS WELL AS CONSULTATION WITH BIOONE'S PARTNERS AS APPLICABLE. THE ANNUAL PERFORMANCE REVIEW WITH THE EXECUTIVE DIRECTORS COMMITTEE WAS HELD IN AUGUST 2023. IN TURN, THE PRESIDENT/CEO IS RESPONSIBLE FOR THE COMPENSATION OF ALL OTHER EMPLOYEES OF THE ORGANIZATION. SALARIES, BENEFITS, AND ELIGIBLE PROMOTIONS ARE REVIEWED ON AN ANNUAL BASIS AND BENCHMARKED ACROSS A VARIETY OF SOURCES, TO INCLUDE COMPARABLE DATA FROM SIMILAR SIZED NON-PROFIT ORGANIZATIONS, AND PUBLISHED COMPENSATION REPORTS FOR NON-PROFIT ORGANIZATIONS, FOR DC-BASED ORGANIZATIONS, AND FOR ORGANIZATIONS OPERATING IN SCHOLARLY COMMUNICATIONS. ANNUAL ADJUSTMENTS TO EMPLOYEE COMPENSATION ARE INCLUDED AS PART OF THE ANNUAL BUDGET, REVIEWED AND APPROVED BY THE BIOONE BOARD OF DIRECTORS IN NOVEMBER OF EACH YEAR. ADJUSTMENTS RECOMMENDED BY THE CEO OUTSIDE OF THE BUDGET CYCLE SIMILARLY MUST BE REVIEWED AND APPROVED BY THE BIOONE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND AUDITED FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS ARE ALSO POSTED ON THE ORGANIZATION'S WEBSITE. FORM 990, PART XI, LINE 9: SURPLUS SHARE -987,659.